ArticleBiomedicines2022

Gb3/cd77 Is a Predictive Marker and Promising Therapeutic Target for Head and Neck Cancer.

Lorena García-Hevia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.